For example, just last month, an alarming new study claimed that long-term cannabis use may cause the frontal cortex to thin ...

Cardiovascular Ultrasound System Market OverviewThe global cardiovascular ultrasound system market is projected to grow steadily over the coming years with an estimated compound annual growth rate of ...

First Olmsted syndrome patient dosed in global Phase 1b studyCompany now operating under its new name, Orvida PharmaNESS ZIONA, Israel, April ...

Scientists are turning to AI and speech analysis to uncover early signs of Alzheimer’s in ways traditional methods may miss.

Orvida Pharma (formerly Kamari Pharma), a privately held clinical-stage biotechnology company developing first and best-in-class treatments for rare and severe genetic skin diseases, today announced ...

Oryon Cell Therapies ("Oryon"), a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders, ...

As more countries and U.S. states legalize cannabis, its use for medical and recreational purposes is growing, but its ...

Regardless of whether you’re on the gummy bandwagon, you might wonder how it really affects your brain after the buzz wears off. About 15.4 percent of Americans older than 12 have used cannabis in the ...

H.817 aims to provide mental health literacy training and peer support in schools to help students. It passed the VT House ...

Full FDA approval establishes sparsentan as the first approved therapy for FSGS, addressing a longstanding reliance on ...

In April 2026, XellSmart officially launches its multicenter Phase II registrational clinical trial of the "Clinical-Grade, Allogeneic, Off-the-Shelf, iPSC-Derived, Dopaminergic Neural Progenitor Cell ...

Americans may be rethinking their affinity for marijuana, evidenced by a New York Times reversal on the issue and a study ...